Search

Your search keyword '"OWUSU, M."' showing total 186 results

Search Constraints

Start Over You searched for: Author "OWUSU, M." Remove constraint Author: "OWUSU, M."
186 results on '"OWUSU, M."'

Search Results

51. Phosphatidylethanol measures in patients with severe COVID-19-associated respiratory failure identify a subset with alcohol misuse.

52. High-density sampling reveals volume growth in human tumours.

54. Global wastewater surveillance for pathogens with pandemic potential: opportunities and challenges.

55. Aspilia africana (Pers.) C.D. Adams and Manihot esculenta Crantz Exhibit Antibacterial Activity against Resistant Salmonella typhi Strains.

56. Risk factors associated with meningitis outbreak in the Upper West Region of Ghana: A matched case-control study.

57. Barriers to HIV testing and possible interventions to improve access to HIV healthcare among migrants, with a focus on migrant women: Results from a European survey.

58. Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study.

59. Aetiological agents of pneumonia among HIV and non-HIV infected children in Ghana: A case-control study.

60. Analyzing Two Decades of Literature on Experiences of Familial Mental Illness Stigma in Four Advanced Countries (2000-2020).

61. Clinical epidemiology, determinants, and outcomes of viral encephalitis in Ghana; a cross-sectional study.

62. Investigating the effect of red beetroot powder concentration and processing time on the bioactive compounds composition and antioxidant capacity of beetroot dark chocolate.

63. Clinical profile and predictors of viral suppression in HIV-infected older adults at a University Hospital in Kumasi, Ghana.

64. Building a postgraduate psychiatry training program in Liberia through cross-country collaborations: initiation stages, challenges, and opportunities.

65. Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population.

66. An impact assessment of the use of aerial logistics to improve access to vaccines in the Western-North Region of Ghana.

68. Plasma levels of fibrinolytic and coagulation biomarkers in HIV-infected individuals on highly active antiretroviral therapy: A case-control study in a Northern Ghanaian population.

69. Effects of COVID-19 disease on PAI-1 antigen and haematological parameters during disease management: A prospective cross-sectional study in a regional Hospital in Ghana.

70. Characterization of Typhoid Intestinal Perforation in Africa: Results From the Severe Typhoid Fever Surveillance in Africa Program.

71. Solid waste motor tricycle operators in Kumasi, Ghana, harbour respiratory pathogens; a public health threat.

72. Understanding the barriers and facilitators to using self-sampling packs for sexually transmitted infections and blood-borne viruses: Thematic analyses for intervention optimization.

73. Retraction.

74. RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa.

75. Using drones to transport suspected COVID-19 samples; experiences from the second largest testing centre in Ghana, West Africa.

76. Using the behaviour change wheel approach to optimize self-sampling packs for sexually transmitted infection and blood borne viruses.

77. SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa.

78. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance.

79. 'This disease is not meant for the hospital, it is Asram': Implications of a traditionally-defined illness on healthcare seeking for children under-5 in rural Ashanti, Ghana.

80. Estimating typhoid incidence from community-based serosurveys: a multicohort study.

81. Genetic characterization of varicella-zoster and HIV-1 viruses from the cerebrospinal fluid of a co-infected encephalitic patient, Ghana.

82. COVID-19 and Burkholderia cepacia co-infection in pregnancy associated with fetal demise: a case report.

84. Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021.

85. Effect of pulmonary tuberculosis on natural anticoagulant activity in therapy-naïve Ghanaian adults; a case-control study.

86. Going beyond 'regular and casual': development of a classification of sexual partner types to enhance partner notification for STIs.

87. Surveillance and laboratory collaboration in response to an outbreak of Vibrio parahaemolyticus, Plesiomonas shigelloides, and Aeromonas hydrophila in Sekondi-Takoradi, Ghana: a case series.

88. User experiences of a mobile phone-based health information and surveillance system (mHISS): A case of caregivers of children under-five in rural communities in Ghana.

89. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.

90. Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection.

91. Evidence of chikungunya virus infections among febrile patients at three secondary health facilities in the Ashanti and the Bono Regions of Ghana.

92. Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma.

93. Anchovy powder enrichment in brown rice-based instant cereal: a process optimization study using Response Surface Methodology (RSM).

94. Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana.

95. Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in Ghana.

96. The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.

97. How can we make self-sampling packs for sexually transmitted infections and bloodborne viruses more inclusive? A qualitative study with people with mild learning disabilities and low health literacy.

98. Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.

99. Genomic and epidemiological characteristics of SARS-CoV-2 in Africa.

100. Common bacteria in sputum or gastric lavage of patients presenting with signs and symptoms of lower respiratory tract infections.

Catalog

Books, media, physical & digital resources